|
RNASEH2B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.063600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.562200E-01 |
| Normal-vs-Stage2 |
1.837550E-02 |
| Normal-vs-Stage3 |
6.918400E-02 |
| Normal-vs-Stage4 |
5.814700E-04 |
| Stage1-vs-Stage2 |
8.020300E-02 |
| Stage1-vs-Stage3 |
3.203800E-01 |
| Stage1-vs-Stage4 |
1.397240E-03 |
| Stage2-vs-Stage3 |
2.812200E-01 |
| Stage2-vs-Stage4 |
7.780800E-01 |
| Stage3-vs-Stage4 |
8.425800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.525900E-02 |
| Normal-vs-AfricanAmerican |
2.781000E-01 |
| Normal-vs-Asian |
1.905880E-02 |
| Caucasian-vs-AfricanAmerican |
5.326200E-01 |
| Caucasian-vs-Asian |
1.162950E-01 |
| AfricanAmerican-vs-Asian |
9.740300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.283640E-02 |
| Normal-vs-Female |
1.069150E-01 |
| Male-vs-Female |
1.016440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.602440E-01 |
| Normal-vs-Age(41-60Yrs) |
6.288000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.248420E-02 |
| Normal-vs-Age(81-100Yrs) |
2.639800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.238000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.974200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.257200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.853400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.630200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.628400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.628000E-01 |
| Normal-vs-Grade 2 |
8.662400E-02 |
| Normal-vs-Grade 3 |
7.220000E-03 |
| Normal-vs-Grade 4 |
7.179400E-03 |
| Grade 1-vs-Grade 2 |
4.198200E-01 |
| Grade 1-vs-Grade 3 |
1.876800E-01 |
| Grade 1-vs-Grade 4 |
1.367020E-01 |
| Grade 2-vs-Grade 3 |
1.696200E-01 |
| Grade 2-vs-Grade 4 |
8.593900E-02 |
| Grade 3-vs-Grade 4 |
4.470400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.321200E-01 |
| Normal-vs-ccB subtype |
1.759510E-02 |
| ccA subtype-vs-ccB subtype |
1.147790E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.402100E-02 |
| Normal-vs-N1 |
3.213600E-02 |
| N0-vs-N1 |
2.568200E-01 |
|
|
